Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT Pre-market 07:53:08 am
21.02 USD +2.49% Intraday chart for Walgreens Boots Alliance, Inc. 20.68 -1.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Futures Edge Down Pre-Bell as Traders Await Key Economic Reports; Asia Mixed, Europe Higher MT
Walgreens Boots Alliance's Fiscal Q2 Non-GAAP Earnings, Sales Rise; Fiscal 2024 Adjusted EPS Outlook Revised MT
Holiday Caution Caps Wall Street; Asia Mixed, Europe Up MT
Earnings Flash (WBA) WALGREENS BOOTS ALLIANCE Posts Q2 EPS $1.20, vs. Street Est of $0.82 MT
Walgreens narrows full-year profit forecast and takes $5.8 billion impairment RE
European Midday Briefing : Stocks Edge Higher Despite Some Weak Economic Data DJ
North American Morning Briefing : Stocks Set for -2- DJ
BofA Securities Trims Walgreens Boots Alliance's Price Target to $22 From $23, Maintains Underperform Rating MT
Morgan Stanley Trims Price Target on Walgreens Boots Alliance to $21 From $22, Keeps Underweight Rating MT
Walgreens Boots Alliance Likely Benefit From Tax, Cost-Cutting in Q2, UBS Says MT
North American Morning Briefing : Tech in Focus on Reports of China Restrictions DJ
News Highlights : Top Global Markets News of the Day - Monday at 5 AM ET DJ
News Highlights : Top Global Markets News of the Day - Monday at 3 AM ET DJ
News Highlights : Top Global Markets News of the Day - Monday at 1 AM ET DJ
Leerink Partners Adjusts Price Target on Walgreens Boots Alliance to $22 From $23, Maintains Market Perform Rating MT
Global markets live: Adidas, EON, Sandoz, Bayer, Boeing... Our Logo
Not a care in the world Our Logo
Walgreens Boots Alliance to Offer Claire's Products MT
Walgreens settles New York charges it grossly inflated prices of infant formula RE
Independent Testing Laboratory Says Cancer-Causing Chemical Detected in Certain Acne Treatments MT
Cancer-causing chemical found in Clinique, Clearasil acne treatments RE
Sector Update: Health Care Stocks Mixed Late Afternoon MT
Sector Update: Health Care Stocks Softer in Afternoon Trading MT
Sector Update: Health Care MT
Walgreens Boots Alliance Not Planning to Sell Shields Health Solutions Unit, CEO Says MT
Chart Walgreens Boots Alliance, Inc.
More charts
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
21.02 USD
Average target price
25.29 USD
Spread / Average Target
+20.31%
Consensus
  1. Stock
  2. Equities
  3. Stock Walgreens Boots Alliance, Inc. - Nasdaq
  4. News Walgreens Boots Alliance, Inc.
  5. Walgreens Boots Alliance : Credit Suisse Adjusts Walgreens Boots Alliance's Price Target to $46 from $42, Keeps Neutral Rating